Research ArticleAccepted Article
Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort
Esther Mossel, Jolien F. van Nimwegen, Alja J. Stel, Robin F. Wijnsma, Konstantina Delli, Greetje S. van Zuiden, Lisette Olie, Jelle Vehof, Leonoor I. Los, Arjan Vissink, Frans G.M. Kroese, Suzanne Arends and Hendrika Bootsma
The Journal of Rheumatology October 2020, jrheum.200482; DOI: https://doi.org/10.3899/jrheum.200482
Esther Mossel
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Jolien F. van Nimwegen
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Alja J. Stel
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Robin F. Wijnsma
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Konstantina Delli
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Greetje S. van Zuiden
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Lisette Olie
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Jelle Vehof
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Leonoor I. Los
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Arjan Vissink
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Frans G.M. Kroese
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Suzanne Arends
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
Hendrika Bootsma
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. This work was supported by: The Dutch Arthritis Society, research grant for the RESULT cohort; Bristol-Myers Squibb (unrestricted research grant for the RESULT cohort, ); Horizon 2020, a research project supported by the European Commission [H2020-SC1-2016-RTD, proposal 731944]. Address correspondence to Professor H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center, Groningen, University of Groningen, P.O. box 30.001, 9700 RB Groningen, The Netherlands. Email: h.bootsma@umcg.nl
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort
Esther Mossel, Jolien F. van Nimwegen, Alja J. Stel, Robin F. Wijnsma, Konstantina Delli, Greetje S. van Zuiden, Lisette Olie, Jelle Vehof, Leonoor I. Los, Arjan Vissink, Frans G.M. Kroese, Suzanne Arends, Hendrika Bootsma
The Journal of Rheumatology Oct 2020, jrheum.200482; DOI: 10.3899/jrheum.200482
Accepted manuscript
Clinical phenotyping of primary Sjögren’s patients using salivary gland ultrasonography – data from the RESULT cohort
Esther Mossel, Jolien F. van Nimwegen, Alja J. Stel, Robin F. Wijnsma, Konstantina Delli, Greetje S. van Zuiden, Lisette Olie, Jelle Vehof, Leonoor I. Los, Arjan Vissink, Frans G.M. Kroese, Suzanne Arends, Hendrika Bootsma
The Journal of Rheumatology Oct 2020, jrheum.200482; DOI: 10.3899/jrheum.200482